Literature DB >> 8044804

Integrins and laminins in human renal carcinoma cells and tumors grown in nude mice.

M Korhonen1, H Sariola, V E Gould, L Kangas, I Virtanen.   

Abstract

We studied by indirect immunofluorescence microscopy the distribution of integrins and laminins in four human renal cell carcinoma cell lines (CAKI-2, A498, CAKI-1, and ACHN) in vitro and in s.c. xenografts in nude mice. In vitro, all four cell lines expressed the alpha 1, alpha 3, alpha v, beta 1, beta 3, and beta 5 subunits and three expressed the alpha 6 subunit; all cell lines expressed laminin A, B1, and B2 chains. Histologically, the CAKI-2 and A498 cells formed differentiated grade 1 (G1) and G2 tumors, respectively, while the CAKI-1 and ACHN cells formed poorly differentiated G3 tumors. The described integrin profile was largely retained upon xenografting. Basal polarization of the alpha 3 and alpha 6 integrin subunits was found in the differentiated tumors, and human laminins were detected as discrete linear structures surrounding tumor cell clusters in these tumors, suggesting that the cells have retained a polarized cell-laminin interaction characteristic of normal tubular epithelial cells. A disorganized distribution of integrins and laminins was noted in the G3 tumors. We conclude that these renal carcinoma cell lines displayed an integrin repertoire similar to that of clinical renal carcinomas and retained it upon xenografting. Furthermore, the organization of integrins and laminins in the xenografts correlated with histological grade.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8044804

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma.

Authors:  A Jungwirth; A V Schally; J Pinski; K Groot; P Armatis; G Halmos
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

Review 2.  Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects.

Authors:  H Kosmehl; A Berndt; D Katenkamp
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

Review 3.  Choosing The Right Animal Model for Renal Cancer Research.

Authors:  Paweł Sobczuk; Anna Brodziak; Mohammed Imran Khan; Stuti Chhabra; Michał Fiedorowicz; Marlena Wełniak-Kamińska; Kamil Synoradzki; Ewa Bartnik; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Transl Oncol       Date:  2020-02-22       Impact factor: 4.243

4.  Laminin 5 in the human thymus: control of T cell proliferation via alpha6beta4 integrins.

Authors:  M Vivinus-Nebot; M Ticchioni; F Mary; P Hofman; V Quaranta; P Rousselle; A Bernard
Journal:  J Cell Biol       Date:  1999-02-08       Impact factor: 10.539

5.  PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma.

Authors:  Basudev Chowdhury; Elizabeth G Porter; Jane C Stewart; Christina R Ferreira; Matthew J Schipma; Emily C Dykhuizen
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

Review 6.  Choosing the right cell line for renal cell cancer research.

Authors:  Klaudia K Brodaczewska; Cezary Szczylik; Michal Fiedorowicz; Camillo Porta; Anna M Czarnecka
Journal:  Mol Cancer       Date:  2016-12-19       Impact factor: 27.401

Review 7.  Modeling clear cell renal cell carcinoma and therapeutic implications.

Authors:  Melissa M Wolf; W Kimryn Rathmell; Kathryn E Beckermann
Journal:  Oncogene       Date:  2020-03-02       Impact factor: 9.867

8.  Interactions between TGF-β type I receptor and hypoxia-inducible factor-α mediates a synergistic crosstalk leading to poor prognosis for patients with clear cell renal cell carcinoma.

Authors:  Pramod Mallikarjuna; Tumkur Sitaram Raviprakash; Karthik Aripaka; Börje Ljungberg; Marene Landström
Journal:  Cell Cycle       Date:  2019-07-24       Impact factor: 4.534

9.  Renal carcinoma CD105-/CD44- cells display stem-like properties in vitro and form aggressive tumors in vivo.

Authors:  M Fiedorowicz; M I Khan; D Strzemecki; J Orzeł; M Wełniak-Kamińska; A Sobiborowicz; M Wieteska; Z Rogulski; L Cheda; W Wargocka-Matuszewska; K Kilian; C Szczylik; A M Czarnecka
Journal:  Sci Rep       Date:  2020-03-25       Impact factor: 4.379

10.  CDH6-activated αIIbβ3 crosstalks with α2β1 to trigger cellular adhesion and invasion in metastatic ovarian and renal cancers.

Authors:  Rubén A Bartolomé; Javier Robles; Ángela Martin-Regalado; Laura Pintado-Berninches; Miranda Burdiel; Marta Jaén; Carmen Aizpurúa; Juan I Imbaud; José Ignacio Casal
Journal:  Mol Oncol       Date:  2021-05-02       Impact factor: 6.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.